Form 8-K - Current report:
SEC Accession No. 0001493152-25-002537
Filing Date
2025-01-16
Accepted
2025-01-16 14:12:40
Documents
22
Period of Report
2025-01-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50447
2 ex4-1.htm EX-4.1 124586
3 ex5-1.htm EX-5.1 9530
4 ex10-1.htm EX-10.1 136164
5 ex10-2.htm EX-10.2 245135
6 ex99-1.htm EX-99.1 15489
7 ex99-2.htm EX-99.2 14891
8 ex5-1_001.jpg GRAPHIC 25395
9 ex5-1_002.jpg GRAPHIC 25115
  Complete submission text file 0001493152-25-002537.txt   974351

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE aztr-20250114.xsd EX-101.SCH 3018
11 XBRL LABEL FILE aztr-20250114_lab.xml EX-101.LAB 34240
12 XBRL PRESENTATION FILE aztr-20250114_pre.xml EX-101.PRE 24167
25 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3676
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41705 | Film No.: 25535261
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)